Qualified investors can attend for free. Please check qualifying T&Cs before you register



Qualified investors attend for free

Qualified investors include:

1. Senior management or investment staff with a Fund (ETF, mutual fund, or other non- bank institution) currently invested in life sciences.
2. Senior management or investment staff from a pension or employee benefit plan currently invested in life sciences.
3. Senior management at a family office currently or previously invested in life sciences.
4. Senior leadership or management with a venture or private equity firm managing assets of $25 million or more.
5. Senior management at an angel investor fund (or group) currently or previously invested in life sciences. Not individual Angels.
6. Senior management at a charitable or not-for-profit organization with a fund of $5 million or more currently invested in the life sciences.
7. Research Analyst for a fund currently invested in UK/EU/US/Asian life science companies.

An investor who receives complimentary registration is expected to participate in the One- on-One Partnering, with at least two meetings secured through the system with life science companies.

Attendees who do not qualify for complimentary registration include:
1. Executives who invest personal, disposable income, who's salaried occupation is not that of a full time investor (i.e. not individual Angels)
2. Firms who offer advisory or consulting services of any nature
3. Firms who offer brokerage services of any nature.
4. Crowd funding platforms. 
5. Service providers/consultants to the biotech industry.
6. Biotech/ life sciences company employee or product suppliers to the biotech industry including CRO’s and CMO’s.
7. Firms that provide services and/or charge a fee to biotech companies in exchange for research/media/investor relations coverage.
8. Retail/individual investors.
9. Investment and merchant bankers.
10. Real estate development professionals.
11. Members of economic development organizations.
12. Firms who have a service providing component to their fund’s business model will be evaluated on a case by case basis. If this fund’s information is NOT located in any mainstream database (Ipreo, FactSet), LSX may ask for references for investor qualification.

LSX reserves the right, in its sole discretion, to make the determination of the proper classification of an investor or registrant. Depending on this classification, registration fees may be required.

LSX reserves the right to publish materials and restrict conference and/or partnering system access consistent with these determinations.

If you have any questions please contact





Investors & strategics

Investors engaged across Biotech, Healthtech, Medtech TechBio. See a list

4Bio Capital-1

Albion Capital Logo

ALSA Ventures Logo

Amboy Street Ventures

Apollo Health Ventures Logo

Arix Bioscience Logo

Arrowfield Capital Logo

Ascension Logo

Apple Tree Partners Logo

AurorA Science 300x


Backed VC

Beacon Capital

Biovision Ventures 300 150

British AustralAsia Technology Incubator Logo

Calculus Capital 300x150

Cambridge Innovation Capital Logo

Catalytic Impact Foundation Logo

Claret Capital Partners

Daewoong Innovation Holdings


Downing Ventures Logo

Earlybird Venture Capital Logo

Eir Ventures Logo

EQT Life Sciences Logo

F-Prime Capital 300x150

Flerie Invest Logo

GEM Investment Group

GGS Associates Logo

Global Brain Logo

H Tree Capital

Heuristic Capital

High-Tech Gründerfonds

Human Alfa 300x150

Bio Capital Impact Fund

Imperial College Health Partners

Inveready Logo

IP Group Logo

IPF Partners Logo

Kyto Technology & Life Science 300x

LifeArc Ventures Logo

Longwall Ventures-2-1

M. Ventures-1

Meltwind Logo

Merck Ventures-1

New Enterprise Associates


Nurture Ventures Logo

Octopus Ventures Logo

Oxford Science Enterprises Logo

Panakes Partners Logo

Parkwalk Advisors Logo

Peppermint Venture Partners Logo

Pioneer group 150 300

Prevail Partners Logo

Pureos Bioventures Logo

Queens Park Equity

RYSE Asset Management 150 300

Seroba Life Sciences Logo

Ship2B Ventures

Softbank Vision Fund

Sony Innovation Fund

Sound BioVentures Logo

Syncona Logo

Team8 Group Logo

The Capital Partnership 300x150

The Pioneer Group Logo

Truffle Capital Logo

UCB Ventures Logo

UKI2S Logo

Kurma Partners Logo

Wellington Partners Logo